- Home
- KALA vs BOWN Comparison
KALA vs BOWN Comparison
Compare KALA & BOWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- BOWN
- Stock Information
- Founded
- KALA 2009
- BOWN 2023
- Country
- KALA United States
- BOWN United States
- Employees
- KALA N/A
- BOWN N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- BOWN
- Sector
- KALA Health Care
- BOWN
- Exchange
- KALA Nasdaq
- BOWN Nasdaq
- Market Cap
- KALA 26.2M
- BOWN 28.5M
- IPO Year
- KALA 2017
- BOWN 2023
- Fundamental
- Price
- KALA $6.16
- BOWN $9.20
- Analyst Decision
- KALA Strong Buy
- BOWN
- Analyst Count
- KALA 3
- BOWN 0
- Target Price
- KALA $14.00
- BOWN N/A
- AVG Volume (30 Days)
- KALA 125.5K
- BOWN 2.5K
- Earning Date
- KALA 08-05-2025
- BOWN 01-01-0001
- Dividend Yield
- KALA N/A
- BOWN N/A
- EPS Growth
- KALA N/A
- BOWN N/A
- EPS
- KALA N/A
- BOWN 0.02
- Revenue
- KALA N/A
- BOWN N/A
- Revenue This Year
- KALA N/A
- BOWN N/A
- Revenue Next Year
- KALA N/A
- BOWN N/A
- P/E Ratio
- KALA N/A
- BOWN $201.47
- Revenue Growth
- KALA N/A
- BOWN N/A
- 52 Week Low
- KALA $2.92
- BOWN $2.71
- 52 Week High
- KALA $11.20
- BOWN $19.77
- Technical
- Relative Strength Index (RSI)
- KALA 58.29
- BOWN 43.24
- Support Level
- KALA $5.39
- BOWN $9.14
- Resistance Level
- KALA $7.00
- BOWN $10.20
- Average True Range (ATR)
- KALA 0.71
- BOWN 0.39
- MACD
- KALA 0.04
- BOWN -0.03
- Stochastic Oscillator
- KALA 51.89
- BOWN 39.35
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About BOWN Bowen Acquisition Corp
Bowen Acquisition Corp is a blank check company.